Replies to post #273867 on NorthWest Biotherapeutics Inc (NWBO)

[XenaLives]

One thing that is sorely missing from the U.S. healthcare system is solid risk/reward data. I would also like to see more use of supplements rather than drugs by main stream doctors.

These complex issues are now being discussed in the Trump presentation. It is clear that we do not know now.

[Poor Man -]

There is a tension between the health impact of the virus on the population versus the health of the economy. But since we’re In the early stages of this crisis, there may not be any choice other than to give containing the infection rate a priority. There will not be much of an economy if everyone goes back to work and the infection numbers are peaking in the millions within a a short period of time.

The second order (ripple) effects are going to be very severe across the economy. And money doesn’t grow on trees, so the macro economic effects will also need to be addressed over many years as a function of the large fiscal deficits. But I’m not sure there is much that can be done at this point, other than deal with slowing the spread of the virus.

[jammyjames]

I’m a PhD not an MD. I do agree with you that the economy should not be totally ignored….it’s a fine balance and i don’t know where exactly that balance sits. It’s sad to say but in reality a price is put on a life...that’s the whole point behind quality of life years and how appraisal bodies such as NICE in the UK will only pay a certain amount of money per QOLY. Also indirectly people die if the economy doesn’t do well (for one like you say that 2.2T could have been spent else where) as for example it leads to delays in new efficacious (IMO) drug treatments like DCVax-L;-) getting trialed, approved and coming to market...there!..i managed to keep a post on topic!haha